Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5c0e49ed6fbd514aa5d070bbfafeae8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7adde5f00da37ebcefd79d76ee584da3 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2027-004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0464 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M27-006 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M27-00 |
filingDate |
2020-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff0d952df548774cb1b3160ef2fe2b3e |
publicationDate |
2021-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021085936-A1 |
titleOfInvention |
Cerebrospinal fluid diversion for the treatment of chronic fatigue syndrome and fibromyalgia and use of rnfl thinning as a biomarker therefor |
abstract |
This application discloses methods and tools for the treatment of chronic fatigue syndrome (CFS) and fibromyalgia and the use of retinal nerve fiber layer thinning as a biomarker for the treatment. |
priorityDate |
2019-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |